论文部分内容阅读
目的 分析急性 ST 段抬高型心肌梗死(STEMI)在基层医院溶栓治疗的安全性。方法 随机抽取我院收治的35例急性STEMI患者,及时予以常规治疗,同时进行溶栓治疗,分析患者治疗效果。结果 35例患者血管再通28例(80.0%),治疗期间无严重不良反应,血常规、凝血功能正常;3例患者齿龈轻度出血,无消化道及颅内出血,7例行转诊冠脉介入术(PCI)治疗,住院期间无死亡病例。结论 基层医院在治疗急性STEMI患者时及早予以溶栓治疗,安全性高,疗效好,同时也为转诊PCI赢得了时间。
Objective To analyze the safety of thrombolytic therapy in acute ST-elevation myocardial infarction (STEMI) in primary hospitals. Methods A total of 35 acute STEMI patients admitted to our hospital were selected randomly and routinely. Thrombolytic therapy was performed at the same time and the therapeutic effect was analyzed. Results Twenty-five patients (80.0%) had recanalization without serious adverse reactions and had normal blood coagulation function. Three patients had mild gingival bleeding without digestive tract and intracranial hemorrhage, and 7 patients were referred with coronary artery Interventional (PCI) treatment, no deaths during hospitalization. Conclusions The primary hospital is thrombolytic therapy in the treatment of acute STEMI patients with high safety and good curative effect. It also won the time for the referral of PCI.